Elite Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.003; its P/E ratio is 23.59; Elite Pharmaceuticals is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 9.00M	$ 8.65M	$ 9.25M	$ 8.59M	$ 7.67M
Gross Profit	$ 4.75M	$ 3.85M	$ 4.92M	$ 3.82M	$ 4.00M
EBIT	$ 1.42M	$ 155.48K	$ 3.33M	$ 1.77M	$ 522.67K
EBITDA	$ 1.75M	$ 485.40K	$ 3.65M	$ 2.09M	$ 869.98K
Net Income Common Stockholders	$ 1.14M	$ -1.23M	$ 2.97M	$ 1.52M	$ 305.88K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 9.08M	$ 7.83M	$ 17.91M	$ 18.56M	$ 19.78M
Total Assets	$ 46.50M	$ 40.90M	$ 52.72M	$ 50.34M	$ 48.11M
Total Debt	$ 7.84M	$ 3.89M	$ 15.98M	$ 16.06M	$ 14.63M
Net Debt	$ -1.24M	$ -3.94M	$ -1.93M	$ -2.49M	$ -5.15M
Total Liabilities	$ 16.38M	$ 11.94M	$ 22.54M	$ 23.15M	$ 22.58M
Stockholders Equity	$ 30.12M	$ 28.96M	$ 30.17M	$ 27.19M	$ 25.53M
Cash Flow	-
Free Cash Flow	$ -2.71M	$ 2.43M	$ -568.59K	$ -3.61M	$ -652.11K
Operating Cash Flow	$ -2.71M	$ 2.97M	$ -567.88K	$ 1.50M	$ -557.52K
Investing Cash Flow	-	$ -536.21K	$ -711.00	$ -5.11M	$ -94.60K
Financing Cash Flow	$ 3.96M	$ -12.50M	$ -77.37K	$ 2.39M	$ 11.90M

Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

Income Statement >

Elite Pharmaceuticals Debt to Assets

Balance Sheet >

Elite Pharmaceuticals Cash Flow

Cash Flow >

Elite Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing